| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31,936 |
26,136 |
$1.36M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,706 |
25,107 |
$1.29M |
| 93880 |
|
5,044 |
4,964 |
$958K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,878 |
2,819 |
$817K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
19,624 |
13,690 |
$505K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
4,079 |
3,976 |
$463K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
8,451 |
7,198 |
$427K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
3,023 |
2,944 |
$348K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
8,378 |
7,194 |
$329K |
| 99497 |
|
3,488 |
3,421 |
$282K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,535 |
2,457 |
$219K |
| 93000 |
|
5,875 |
5,719 |
$202K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,273 |
5,261 |
$144K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,815 |
3,242 |
$132K |
| G9920 |
Screening performed and negative |
2,147 |
2,013 |
$65K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,185 |
1,114 |
$56K |
| 99406 |
|
3,785 |
3,254 |
$45K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
2,217 |
2,099 |
$37K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,890 |
1,854 |
$34K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
5,115 |
4,996 |
$33K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
4,160 |
4,078 |
$25K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
293 |
286 |
$24K |
| 90756 |
|
728 |
723 |
$23K |
| 90674 |
|
697 |
671 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,731 |
4,462 |
$22K |
| 99205 |
Prolong outpt/office vis |
200 |
199 |
$17K |
| 99215 |
Prolong outpt/office vis |
298 |
274 |
$13K |
| 90655 |
|
296 |
296 |
$10K |
| 96127 |
|
1,641 |
1,577 |
$9K |
| 93923 |
|
87 |
82 |
$9K |
| 93925 |
|
90 |
85 |
$8K |
| 94060 |
|
99 |
90 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
69 |
65 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
119 |
114 |
$3K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
15 |
15 |
$3K |
| 90661 |
|
44 |
44 |
$2K |
| 76536 |
|
32 |
31 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
95 |
86 |
$1K |
| 93922 |
|
20 |
20 |
$1K |
| 81002 |
|
515 |
494 |
$846.35 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
52 |
52 |
$563.08 |
| S0257 |
Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service) |
1,773 |
1,748 |
$530.42 |
| 81025 |
|
189 |
185 |
$484.40 |
| 88142 |
|
483 |
465 |
$376.88 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
51 |
49 |
$353.92 |
| 92250 |
|
18 |
12 |
$315.96 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,059 |
1,030 |
$147.26 |
| S0613 |
Annual gynecological examination; clinical breast examination without pelvic evaluation |
890 |
871 |
$88.54 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
4,394 |
3,146 |
$79.42 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
19,923 |
14,111 |
$79.42 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
964 |
797 |
$46.93 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
869 |
719 |
$46.93 |
| 86580 |
|
12 |
12 |
$40.32 |
| 94664 |
|
94 |
86 |
$7.74 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
87 |
79 |
$3.49 |
| 3080F |
|
1,557 |
1,381 |
$0.00 |
| 3044F |
|
468 |
429 |
$0.00 |
| 3061F |
|
19 |
18 |
$0.00 |
| 1157F |
|
1,368 |
1,341 |
$0.00 |
| 3074F |
|
14,796 |
11,620 |
$0.00 |
| 3079F |
|
5,298 |
4,497 |
$0.00 |
| 3075F |
|
2,904 |
2,584 |
$0.00 |
| 3052F |
|
12 |
12 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
2,062 |
1,593 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
211 |
165 |
$0.00 |
| 1111F |
|
12 |
12 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
53 |
53 |
$0.00 |
| 3078F |
|
13,288 |
10,652 |
$0.00 |
| 3077F |
|
2,571 |
2,226 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
86 |
74 |
$0.00 |
| 1160F |
|
771 |
635 |
$0.00 |
| 3046F |
|
12 |
12 |
$0.00 |
| 1159F |
|
744 |
610 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
438 |
431 |
$0.00 |
| 3051F |
|
31 |
25 |
$0.00 |
| 1158F |
|
58 |
57 |
$0.00 |